# Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients

> **NCT06924697** · NA · ENROLLING_BY_INVITATION · sponsor: **Shanghai East Hospital** · enrollment: 46 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Nicotine Dependence, Cigarettes

## Interventions

- **DRUG:** Application of GLP-1RAs drugs
- **DRUG:** DPP-4i group

## Key facts

- **NCT ID:** NCT06924697
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-06-21
- **Primary completion:** 2026-01-11
- **Final completion:** 2026-07-01
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06924697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06924697, "Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06924697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*